Dr. Trevor Cornelius Stuart Archer
My Social Links

Dr. Trevor Cornelius Stuart Archer

Professor
University of Orebro, Sweden

Highest Degree
Ph.D. in Psychology from Uppsala University, Uppsala, Sweden

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Brain Research
62%
Neurotoxicity Research
90%
Neurodegenerative Disorders
75%
Psychology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Onofri, E., M. Mercuri, M.L. Salesi, S. Ferrara and G.M. Troili et al., 2013. Dysgraphia in relation to cognitive performance in patients with Alzheimer's disease. J. Intellect. Disabil. Diagnosis Treatment, 1: 113-124.
    Direct Link  |  
  2. Lindahl, M. and T. Archer, 2013. Depressive expression and antidepressive protection: Positive affect, motivation and self-efficacy. Pychol. J., 4: 495-505.
  3. Adrianson, L., D. Ancok, N. Ramdhani and T. Archer, 2013. Cultural influences upon health, affect, self-esteem and impulsiveness: An Indonesian-Swedish comparison. Int. J. Res. Stud. Psychol. .
    Direct Link  |  
  4. Scharin, M., T. Archer and P. Hellstrom, 2012. Affective spectrum disorders in an urban Swedish adult psychiatric unit: A descriptive study. Depress. Res. Treatment. .
  5. Pagels, P., A. Raustorp, T. Archer, U. Lidman and M. Alricsson, 2012. Influence of moderate, daily physical activity on body composition and blood lipid profile in Swedish adults. J. Phys. Activity Health, 9: 867-874.
    PubMed  |  Direct Link  |  
  6. Garcia, D., T. Archer, S. Moradi, Andersson A.C. Arnten, 2012. Exercise frequency, high activation positive affect and psychological well-being: Beyond age, gender and occupation. Psychology, 3: 328-336.
    Direct Link  |  
  7. Garcia, D., T. Archer, S. Moradi and B. Ghiabi, 2012. Waiting in vain: Managing time and customer satisfaction at call centers. psychology, 3: 213-216.
    Direct Link  |  
  8. Garcia, D., N. Kerekes, A.C. Andersson Arnten and T. Archer, 2012. Temperament, character and adolescents' depressive symptoms: Focusing on affect. Depression Res. Res., 10.1155/2012/925372.
    CrossRef  |  PubMed  |  Direct Link  |  
  9. Garcia, D., N. Kerekes and T. Archer, 2012. A will and a proper way leading to happiness: Self-directedness mediates the effect of persistence on Positive Affectivity. Personal. Indiv. Differ., 53: 1034-1038.
    Direct Link  |  
  10. Garcia, D., B. Ghiabi, S. Moradi, A. Siddiqui and T. Archer, 2012. The happy personality: A Tale of two philosophies. In: Psychology of Personality, Morris, E.F. and F.A. Jackson (Ed.). Nova Science Publishers Inc., New York.
  11. Garcia, D. and T. Archer, 2012. When reaching our potential predicts low values: a longitudinal study about performance and organizational values at call centres. J. Serv. Sci. Manage., 5: 313-317.
    Direct Link  |  
  12. Garcia, D. and T. Archer, 2012. Adolescent life satisfaction and well-being. J. Alternat. Med. Res., 4: 271-279.
  13. Archer, T. and R.M. Kostrzewa, 2012. Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory. Neurotox. Res., 21: 195-209.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Archer, T. and P. Bright, 2012. Functional and Structural MRI Studies on Impulsiveness: Attention-Deficit/Hyperactive Disorder and Borderline Personality Disorders. In: Neuroimaging-Cognitive and Clinical Neuroscience, Bright, P. (Ed.). Chapter 10, InTech, Rijeka, Croatia, pp: 205-228.
  15. Archer, T. and A. Fredriksson, 2012. Delayed exercise-induced functional and neurochemical partial restoration following MPTP. Neurotox. Res., 21: 210-221.
    CrossRef  |  PubMed  |  Direct Link  |  
  16. Al Nima, A., T. Archer and D. Garcia, 2012. Adolescents' happiness-increasing strategies, temperament and character: Mediation models on subjective well-being. Health, 4: 802-810.
    Direct Link  |  
  17. Karilampi, U., L. Helldin and T. Archer, 2011. Cognition and global assessment of functioning in male and female outpatients with schizophrenia spectrum disorders. J. Nervous Mental Dis., 199: 445-448.
    CrossRef  |  PubMed  |  
  18. Fredriksson, A., I.M. Stigsdotter, A. Hurtig, B. Ewalds-Kvist and T. Archer, 2011. Running wheel activity restores MPTP-induced functional deficits. J. Neural Transmission, 118: 407-420.
    CrossRef  |  PubMed  |  Direct Link  |  
  19. Archer, T., R.M. Kostrzewa, R.J. Beninger and T. Palomo, 2011. Staging neurodegenerative disorders: Structural, regional, biomarker and functional progressions. Neurotox. Res., 19: 211-234.
    CrossRef  |  PubMed  |  Direct Link  |  
  20. Archer, T., M. Oscar-Berman and K. Blum, 2011. Epigenetics in developmental disorder: ADHD and endophenotypes. J. Genet. Syndr. Gene. Therapy, 2: 1-10.
    PubMed  |  Direct Link  |  
  21. Archer, T., B. Johansson and A. Fredriksson, 2011. Exercise alleviates Parkinsonism: Clinical and laboratory evidence. Acta Neurol. Scand., 123: 73-84.
    CrossRef  |  PubMed  |  Direct Link  |  
  22. Archer, T., A. Fredriksson, E. Schutz and R.M. Kostrzewa, 2011. Influence of physical exercise on neuroimmunological functioning and health: Aging and stress. Neurotox. Res., 20: 69-83.
    CrossRef  |  PubMed  |  Direct Link  |  
  23. Archer, T., 2011. Physical exercise alleviates debilities of normal aging and Alzheimer's disease. Acta Neurol. Scand., 123: 221-238.
    CrossRef  |  Direct Link  |  
  24. Archer, T., 2011. Effects of exogenous agents on brain development: Stress, abuse and therapeutic compounds. CNS Neurosci. Ther., 17: 470-489.
    CrossRef  |  PubMed  |  Direct Link  |  
  25. Archer, T. and K. Blum, 2011. Epigenetics in Neuropsychiatry. In: OMICS: Biomedical Perspectives and Applications, Barh, D., K. Blum and M.A. Madigan (Eds.). Chapter 25, CRC Press, San Diego, California.
  26. Archer, T., R.M. Kostrzewa, R.J. Beninger and T. Palomo, 2010. Staging perspectives in neurodevelopmental aspects of neuropsychiatry: Agents, phases and ages at expression. Neurotox. Res., 18: 287-305.
    CrossRef  |  PubMed  |  Direct Link  |  
  27. Archer, T., R.M. Kostrzewa, T. Palomo and R.J. Beninger, 2010. Clinical staging in the pathophysiology of psychotic and affective disorders: Facilitation of prognosis and treatment. Neurotox. Res., 18: 211-228.
    CrossRef  |  PubMed  |  Direct Link  |  
  28. Archer, T., R.J. Beninger, T. Palomo and R.M. Kostrzewa, 2010. Epigenetics and biomarkers in the staging of neuropsychiatric disorders. Neurotox. Res., 18: 347-366.
    CrossRef  |  PubMed  |  Direct Link  |  
  29. Archer, T., 2010. Stages in the pathophysiology and eventual treatment of brain disorders. Eur. J. Psychiatry, 24: 5-8.
  30. Archer, T., 2010. Neurodegeneration in Schizophrenia. Exp. Rev. Neurotherapeut., 10: 1131-1141.
    CrossRef  |  Direct Link  |  
  31. Archer, T. and R.M. Kostrzewa, 2010. Staging neurological disorders: Expressions of cognitive and motor disorder. Neurotox. Res., 18: 107-111.
    CrossRef  |  PubMed  |  Direct Link  |  
  32. Archer, T. and A. Fredriksson, 2010. Physical exercise restores MPTP-induced deficits in mice: Standard long-term and progressive-incremental neurotoxin administration. Neurotox. Res., 18: 313-327.
  33. Andersson-Arnten, A. and T. Archer, 2010. Sexual Satisfaction as a Function of Partnership Attributes and Health Characteristics: Effect of Gender. In: Psychological Wellbeing, Wells, I.E. Ed.). Nova Science Publishers Inc., New York.
  34. Zoller, M., E. Karlsson and T. Archer, 2009. Self-rated affect among adults presentin psychiatric diagnosis. Individ. Differ. Res., 7: 14-28.
    Direct Link  |  
  35. Zoller, M. and T. Archer, 2009. Predicting stress in male and female psychiatric patients and healthy volunteers. Social Behav. Personal., 37: 1081-1094.
    CrossRef  |  Direct Link  |  
  36. Raustorp, A., T. Archer, K. Svensson, T. Perlinger and M. Alricsson, 2009. Physical self-esteem, a five year follow-up study on Swedish adolescents. Int. J. Adolescent Med. Health, 21: 497-507.
    PubMed  |  Direct Link  |  
  37. Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer, 2009. Symptom Veracity and Diagnostic Veniality in Brain Dysfunction: Conscious and Nonconscious Expression in Impulsiveness and Decision-making. In: Beyond Neuropsychiatric Diagnosis: Symptoms Not Disorders, Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer (Eds.). F.P. Graham Publishing, Mountain Home, Idaho, pp: 3-37.
  38. Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer, 2009. Beyond Neuropsychiatric Diagnosis: Symptoms not Disorders. F.P. Graham Publishing, Mountain Home, USA., pp: 7-12.
  39. Palomo, T., R.M. Kostrzewa, R.J. Beninger and T. Archer, 2008. Schizopsychotic symptom-profiles and biomarkers: Beacons in diagnostic labyrinths. Neurotox. Res., 14: 79-96.
    CrossRef  |  PubMed  |  
  40. Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer, 2008. Focusing on symptoms rather than diagnoses in brain dysfunction: Conscious and nonconscious expression in impulsiveness and decision-making. Neurotox. Res., 14: 1-20.
    Direct Link  |  
  41. Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer, 2008. Affective status in relation to impulsive, motor and motivational symptoms: Personality, development and physical exercise. Neurotox. Res., 14: 151-168.
    CrossRef  |  PubMed  |  Direct Link  |  
  42. Karlsson, E. and T. Archer, 2008. Affective state, stress and Type A-personality as a function of gender and affective personality. Soc. Behav. Personal., 36: 20-20.
  43. Hellstrom, P., T. Archer, M. Tullberg and C. Wikkelso, 2008. Neuropsychological effects of shunt surgery in patients with clinically diagnosed idiopathic normal pressure hydroencephalus (INPH). Neurosurgery, 63: 527-535.
  44. Archer, T., R.M. Kostrzewa, R.J. Beninger and T. Palomo, 2008. Cognitive symptoms facilitatory for diagnoses in neuropsychiatric disorders: Executive functions and locus of control. Neurotox. Res., 14: 205-225.
    CrossRef  |  PubMed  |  Direct Link  |  
  45. Archer, T., B. Adolfsson and E. Karlsson, 2008. Affective personality as cognitive-emotional presymptom profiles regulatory for self-reported health predispositions. Neurotox. Res., 14: 1-25.
    CrossRef  |  PubMed  |  Direct Link  |  
  46. Archer, T., 2008. Identifying symptoms in diagnostic labyrinths: Adaptive beacons from biomarkers and genetic polymorphisms. Eur. J. Psychiatry, 22: 9-16.
  47. Palomo, T., T. Archer, R.M. Kostrzewa and R.J. Beninger, 2007. Comorbidity of substance abuse with other psychiatric disorders. Neurotox. Res., 12: 17-27.
  48. Palomo, T., R.M. Kostrzewa, R.J. Beninger and T. Archer, 2007. Genetic variation and shared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotox. Res., 12: 29-42.
    CrossRef  |  PubMed  |  Direct Link  |  
  49. Palomo, T., R.M. Kostrzewa, R.J. Beninger and T. Archer, 2007. Comorbidity implications in brain disease: Neuronal substrates of symptom profiles. Neurotox. Res., 12: 1-15.
    CrossRef  |  PubMed  |  Direct Link  |  
  50. Palomo, T., R.M. Kostrzewa, R.J. Beninger and T. Archer, 2007. Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders. Neurotox. Res., 12: 43-60.
    CrossRef  |  PubMed  |  Direct Link  |  
  51. Karlsson, E. and T. Archer, 2007. Relationship between personality characteristics and affect: Gender and affective personality. Individ. Differ. Res., 5: 44-58.
    Direct Link  |  
  52. Karilampi, U., L. Helldin, F. Hjarthag, T. Norlander and T. Archer, 2007. Cognitive functioning in male and female schizophrenic outpatients and healthy volunteers: Influence of learning performance level. Arch. Clin. Neuropsychol., 22: 161-174.
  53. Helldin, L., J.M. Kane, U. Karilampi, T. Norlander and T. Archer, 2007. Remission in prognosis of functional outcome: A new dimension in the treatment of patients with psychotic disorders. Schizophr Res., 93: 160-168.
    CrossRef  |  PubMed  |  Direct Link  |  
  54. Fredriksson, A. and T. Archer, 2007. Postnatal iron overload destroys NA-DA functional interactions. J. Neural Transmiss., 114: 137-150.
    CrossRef  |  Direct Link  |  
  55. Archer, T., L. Adrianson, A. Plancak and E. Karlsson, 2007. Influence of affective personality on cognition-mediated emotional processing: Need for empowerment. Eur. J. Psychiatry, 21: 248-262.
    CrossRef  |  
  56. Archer, T., R.J. Beninger and W.J. Schmidt, 2007. (1950-2007) pushing the envelope of neuroscience: A true academician and complete gentleman. Neurotox. Res., 12: 1-4.
  57. Archer, T. and A. Fredriksson, 2007. Iron Influence Upon Dopaminergic and Noradrenergic Contributions to Movement Disorder and Psychotic Behaviour. In: Comorbidity in Neuropsychiatric Disorders, Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer (Eds.). Cerebro y Mente Publications, Madrid.
  58. Archer, T. and A. Fredriksson, 2007. Functional consequences of iron overload in catecholaminergic interactions: The Youdim factor. Neurochem. Res., 32: 1625-1639.
    CrossRef  |  PubMed  |  Direct Link  |  
  59. Archer, T. and A. Fredriksson, 2007. Behavioural supersensitivity following neonatal 6-hydroxydopamine: Attenuation by MK-801. Neurotox. Res., 12: 113-124.
    CrossRef  |  PubMed  |  Direct Link  |  
  60. Wass, C., T. Archer, E. Palsson, K. Fejgin, D. Klamer, J. Engel and L. Svensson, 2006. Effects of phencyclidine on spatial learning and memory: Nitric oxide-dependent mechanisms. Behav. Brain Res., 171: 147-153.
    CrossRef  |  PubMed  |  Direct Link  |  
  61. Wass, C., Archer, T., Palsson, E., Fejgin and A. Alexandersson et al., 2006. Phencyclidine affects memory in a Nitric oxide-dependent manner: Working and reference memory. Behav. Brain Res., 174: 49-55.
    CrossRef  |  PubMed  |  Direct Link  |  
  62. Svensson, J., M. Diez, J. Engel, C. Wass and A. Tivesten et al., 2006. Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J. Endocrinol., 189: 617-627.
    PubMed  |  Direct Link  |  
  63. Helldin, L., U. Karilampi, T. Norlander and T. Archer, 2006. Functional determinants of cognitive performance and symptom profile in a cohort of schizophrenic patients. Psychiatry Res., 40: 738-745.
  64. Helldin, L., J.M. Kane, U. Karilampi, T. Norlander and T. Archer, 2006. Remission and cognitive ability in a cohort of patients with schizophrenia. J. Psychiat. Res., 40: 738-745.
    CrossRef  |  PubMed  |  Direct Link  |  
  65. Fredriksson, A., P. Eriksson and T. Archer, 2006. Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice. J. Neural Transm., 113: 137-150.
    CrossRef  |  PubMed  |  Direct Link  |  
  66. Fredriksson, A. and T. Archer, 2006. Postnatal iron treatment followed by subchronic haloperidol alters motor behaviour in mice. Neurotox. Res., 10: 123-129.
  67. Archer, T., 2006. The Enigmatic Department of Psychology. In: Ett Amne Blir Till Psychologi I Goteborg - En Kort Historia Med Ett Langt Forflutet, 1956-2006 [The Origins of Psychology in Goteborg-a Short Story with a Long History, 1956-2006], Falkhe, C., E. Hjelmquist, I. Lundberg, I. Nilsson and T. Tjus (Eds.). Department of Psychology, Goteborg, pp: 88-92.
  68. Archer, T. and A. Fredriksson, 2006. Influence of noradrenaline denervation upon MPTP-induced deficts in mice. J. Neural Transmiss., 113: 1119-1129.
  69. Agerstrom, J., K. Moller and T. Archer, 2006. Influence of affective personality and level of perfectionism on moral reasoning: Effect of gender. J. Personal. Soc. Psychol., 34: 1259-1276.
  70. Wastlund, E., H. Reinikka, T. Norlander and T. Archer, 2005. Effects of VDT and paper presentation on consumption and production of information: Psychological and physiological factors. Comput. Hum. Behav., 21: 377-394.
    CrossRef  |  
  71. Norlander, T., T. Moas and T. Archer, 2005. Noise and stress in primary and secondary school children: Noise reduction and increased concentration ability through a short but regular exercise and relaxation program. School Effectiv. School Improv.: Int. J. Res. Policy Pract., 16: 91-99.
    CrossRef  |  Direct Link  |  
  72. Norlander, T., H. von Schedvin and T. Archer, 2005. Thriving as a function of affective personality and occupation: Relation to personality factors, coping strategies and stress. Anxiety Stress Cop., 18: 105-116.
  73. Klamer, D., E. Palsson, C. Wass, T. Archer, J. Engel and L. Svensson, 2005. Antagonism of the nitric oxide synthase inhibitor, L-NAME, of the effects of phencyclidine on latent inhibition in taste aversion conditioning. Behav. Brain Res., 161: 60-68.
    PubMed  |  Direct Link  |  
  74. Janson, L., T. Archer and T. Norlander, 2005. Achievement of timing at the highest competitive level: The necessity of a 'Driving conviction'. Athletic Insight, 7: 37-49.
    Direct Link  |  
  75. Archer, T., 2005. Comorbidity influences in neuropsychiatry: Symptom plasticity constraints on etiology and treatment. Eur. J. Psychiatry, 19: 197-207.
  76. Perrin-Wallqvist, R., T. Archer and T. Norlander, 2004. Adolescents' fire-setting awareness under boredom: Relation to personality variables. Psychol. Rep., 94: 863-871.
    PubMed  |  Direct Link  |  
  77. Palsson, E., D. Klamer, C. Wass, T. Archer, J. Engel and L. Svensson, 2004. The effects of phencyclidine on latent inhibition in taste aversion conditioning: Differential effects of preexposure and conditioning. Behav. Brain Res., 157: 139-146.
    PubMed  |  Direct Link  |  
  78. Palomo, T., T. Archer, R.M. Kostrzewa, R.J. Beninger, 2004. Gene-environment interplay in schizopsychotic disorders. Neurotox. Res., 6: 1-10.
    CrossRef  |  PubMed  |  Direct Link  |  
  79. Palomo, T., T. Archer, R.J. Beninger and R.M. Kostrzewa, 2004. Gene-environment interplay in neurodegeneration and neurogenesis. Neurotox. Res., 6: 415-434.
    CrossRef  |  PubMed  |  Direct Link  |  
  80. Palomo, T., R.J. Beninger, RM. Kostrzewa and T. Archer, 2004. Gene-environment interplay in affect and dementia: Emotional modulation of cognitive expression in personal outcomes. Neurotox. Res., 6: 159-173.
    CrossRef  |  PubMed  |  Direct Link  |  
  81. Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer, 2004. Gene-environment interplay in Alcoholism and other substance abuse disorders: Expressions of heritability and factors influencing vulnerabilities. Neurotox. Res., 6: 343-361.
    CrossRef  |  PubMed  |  Direct Link  |  
  82. Kristensson, P., A. Gustafsson and T. Archer, 2004. Harnessing the creative potential among users. J. Product Innovat. Manage., 21: 4-14.
    CrossRef  |  Direct Link  |  
  83. Kjellgren, A., T. Norlander, U. Sundequist and T. Archer, 2004. Altered consciousness in flotation-rest and chamber-rest: Experience of experimental pain and subjective stress. Soc. Behav. Person., 32: 103-116.
    CrossRef  |  Direct Link  |  
  84. Fredriksson, A., T. Archer, H. Alm, T. Gordh and P. Eriksson, 2004. Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav. Brain Res., 153: 367-376.
    CrossRef  |  PubMed  |  
  85. Fredriksson, A. and T. Archer, 2004. Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotoxicity Res., 6: 435-456.
    CrossRef  |  PubMed  |  Direct Link  |  
  86. Bood, S.A., T. Archer and T. Norlander, 2004. Affective personality as determinant of factors influencing stress experience. Individ. Differ. Res., 2: 26-37.
  87. Palomo, T., T. Archer, R.J. Beninger and R.M. Kostrzewa, 2003. Neurodevelopmental aspects of substance abuse. In: Neurodevelopmental Liabilities in Brain Disease States, Beninger, R.J., T. Palomo, R.M. Kostrzewa and T. Archer (Eds.). Fundacion Cerebro y Mente, Madrid, pp: 3-22.
  88. Palomo, T., R.M. Kostrzewa, T. Archer and R.J. Beninger, 2003. Neurodevelopmental liabilities in schizophrenia and affective disorders. In: Neurodevelopmental Liabilities in Brain Disease States, Beninger, R.J., T. Palomo, R.M. Kostrzewa and T. Archer (Eds.). Fundacion Cerebro y Mente, Madrid, pp: 235-254.
  89. Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer, 2003. Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations. Neurotox. Res., 5: 1-27.
    CrossRef  |  PubMed  |  Direct Link  |  
  90. Palomo, T., R.J. Beninger, R.M. Kostrzewa and T. Archer, 2003. Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations. In: Neurodevelopmental Liabilities in Brain Disease States, Beninger, R.J., T. Palomo, R.M. Kostrzewa and T. Archer (Eds.). Fundacion Cerebro y Mente, Madrid, pp: 557-596..
  91. Janson, L., T. Archer and T. Norlander, 2003. Timing in sports performance: Psychophysiological analysis of technique in male and female athletes. Athlet. Insight, 10: 1-10.
    Direct Link  |  
  92. Fredriksson, A., N. Schroder and T. Archer, 2003. Neurobehavioural deficits following Postnatal iron overload: I Spontaneous motor activity. Neurotox. Res., 5: 53-76.
    CrossRef  |  PubMed  |  Direct Link  |  
  93. Fredriksson, A., N. Schoroder and T. Archer, 2003. Neurobehavioural deficits following Postnatal iron overload: II Instrumental learning performance. Neurotox. Res., 5: 77-94.
    CrossRef  |  Direct Link  |  
  94. Fredriksson, A. and T. Archer, 2003. Hyperactivity following postnatal NMDA antagonist treatment: Reversal by D-amphetamine. Neurotox. Res., 5: 549-564.
    CrossRef  |  PubMed  |  Direct Link  |  
  95. Fredriksson, A. and T. Archer, 2003. Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: Behavioral enhancement by L-Dopa-MK-801 co-administration. Behav. Brain Res., 139: 31-46.
    PubMed  |  Direct Link  |  
  96. Archer, T., T. Palomo, R. McArthur and A. Fredriksson, 2003. Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment. Neurotox. Res., 5: 95-109.
    CrossRef  |  PubMed  |  Direct Link  |  
  97. Archer, T., T. Palomo, R. McArthur and A. Fredriksson, 2003. Effects of Acute Administration of DA Agonists On Locomotor Activity: MPTP Versus Neonatal Intracerebroventricular 6-OHDA Treatment. In: Neurodevelopmental Liabilities in Brain Disease States, Beninger, R.J., T. Palomo, R.M. Kostrzewa and T. Archer (Eds.). Fundacion Cerebro y Mente, Madrid, pp: 623-644.
  98. Archer, T., T. Palomo and A. Fredriksson, 2003. Neonatal 6-Hydroxydopamine-Induced Hypo/Hyperactivity: Blockade by Dopamine Reuptake Inhibitors and Effect of Acute D-amphetamine. In: Neurodevelopmental Liabilities in Brain Disease States, Beninger, R.J., T. Palomo, R.M. Kostrzewa and T. Archer (Eds.). Fundacion Cerebro y Mente, Madrid, pp: 207-234.
  99. Archer, T., T. Palomo and A. Fredriksson, 2003. Functional Deficits Following Neonatal Dopamine Depletion and Isolation Housing: Circular Water Maze Acquisition Under Pre-Exposure Conditions and Motor Activity. In: Neurodevelopmental Liabilities in Brain Disease States, Beninger, R.J., T. Palomo, R.M. Kostrzewa and T. Archer (Eds.). Fundacion Cerebro y Mente, Madrid, pp: 399-428.
  100. Archer, T., 2003. Environmental Agents and Vulnerability in Cognitive Deficits. In: Advances in Neurosciences and Clinical Realities: Genetic-Environmental Neurovulnerability in Psychiatry, Palomo, T., R.J. Beninger, M.A. Jimenez-Arriero and E. Huertas (Eds.). Editorial Sintesis, Bristol, UK., pp: 151-179.
  101. Palomo, T., T. Archer, R.J. Beninger and R.M. Kostrzewa, 2002. Neurodevelopmental liabilities of substance abuse. Neurotox. Res., 4: 267-279.
    CrossRef  |  PubMed  |  Direct Link  |  
  102. Palomo, T., R.M. Kostrzewa, T. Archer and R.J. Beninger, 2002. Neurodevelopmental liabilities in schizophrenia and affective disorders. Neurotox. Res., 4: 397-408.
    CrossRef  |  PubMed  |  Direct Link  |  
  103. Palomo, T., R.J. Beninger and T. Archer, 2002. Neuroimaging in Psychiatry. In: Advances in Neurosciences and Clinical Realities: Neuropsychiatry, Palomo, T., R.J. Beninger, M.A. Jimenez-Arriero and T. Archer (Eds.). Editorial Sintesis, Bristol, UK., pp: 197-223.
  104. Norlander, T., S.A. Bood and T. Archer, 2002. Performance during stress by different occupational groups: Affective personality, Age and regularity of physical exercise. Social Behav. Personal., 30: 495-508.
    Direct Link  |  
  105. Norlander, T., H. Bergman and T. Archer, 2002. Relative constancy of personality characteristics and efficacy of a 12-month training program in facilitating coping strategies. Social Behav. Personality, 30: 773-784.
    CrossRef  |  Direct Link  |  
  106. Fredriksson, A. and T. Archer, 2002. Functional alteration by NMDA antagonist: Effects of L-Dopa, neuroleptics drug and postnatal administration. Amino Acids, 23: 111-132.
    CrossRef  |  Direct Link  |  
  107. Folkesson, P., C. Nyberg, T. Archer and T. Norlander, 2002. Football referees' experience of threat and violence: Effects of age, experience and life orientation on outcome of coping strategy. Aggressive Behav., 28: 317-327.
  108. Archer, T., T. Palomo and R.J. Beninger, 2002. Structural and Functional Neuroimaging as an Avenue Towards the Understanding of Brain Abnormalities in Health and Disease. In: Advances in Neurosciences and Clinical Realities: Substance Abuse Disorders, Palomo, T., R.J. Beninger, M.A. Jimenez-Arriero and T. Archer (Eds.). Editorial Sintesis, Bristol, UK., pp: 197-223.
  109. Archer, T., T. Palomo and A.F. Fredriksson, 2002. Restorative effects of glutamate antagonists in experimental parkinsonism. Amino Acids, 23: 71-85.
    CrossRef  |  PubMed  |  
  110. Archer, T., T. Palomo and A. Fredriksson, 2002. Neonatal 6-hydroxydopamine-induced hypo/hyperactivity: Blockade by dopamine reuptake inhibitors and effect of acute D-amphetamine. Neurotox. Res., 4: 247-266.
    CrossRef  |  PubMed  |  Direct Link  |  
  111. Archer, T., T. Palomo and A. Fredriksson, 2002. Functional deficits following neonatal dopamine depletion and isolation housing: Circular water maze acquisition under pre-exposure conditions and motor activity. Neurotox. Res., 4: 503-522.
    CrossRef  |  PubMed  |  
  112. Archer, T. and A. Fredriksson, 2002. Antihypokinesic effect of α2-adrenoceptor agonists upon MPTP-induced behavioural deficits. J. Neural Transmiss., 110: 183-200.
  113. Pramling, N., T. Norlander and T. Archer, 2001. Moral expression in 6-to-7 year-old children's stories in Sweden, Hungary and China: A phenomenological study. Childhood, 8: 361-382.
    CrossRef  |  Direct Link  |  
  114. Pramling, N., T. Norlander and T. Archer, 2001. Conceptualization of the Unknown by 6-, 9- and 14-year-old children: Search for a heffalump. Childhood, 10: 379-392.
    CrossRef  |  
  115. Norlander, T., A. Kjellgren and T. Archer, 2001. The experience of flotation-REST as a function of setting and previous experience of altered state of consciousness. Imagination Cognition Personality, 20: 161-178.
    Direct Link  |  
  116. Norlander, T., A. Blom and T. Archer, 2001. Role of high school teachers in swedish psychology education: Phenomenological circumstances. Qualitative Rep., 7: 1-15.
  117. Fredriksson, A., W. Danysz, G. Quack and T. Archer, 2001. Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice. J. Neural Transm., 108: 167-187.
    CrossRef  |  
  118. Fredriksson, A., N. Schroder, P. Eriksson, I. Izquierdo and T. Archer, 2001. Postnatal iron and adult MPTP induced neurodegeneration and functional deficits in mice. Parkinsonism Related Disorders, 7: 97-105.
  119. Dal-Pizzol, F., F. Klamt, M.L. Frota, M.E. Andrades and F.F. Caregnato et al., 2001. Neonatal iron exposure induces oxidative stress in adult Wistar rat. Mol. Brain Res., 130: 109-114.
    Direct Link  |  
  120. Archer, T., T. Palomo and R.M. Kostrzewa, 2001. Neurotoxicity and substance abuse: Further fuel for regulatory dilemma. Neurotoxicity Res., 3: 1-6.
    CrossRef  |  
  121. Archer, T., T. Palomo and A. Fredriksson, 2001. Functional Expressions of Noradrenergic Receptor Changes Following Denervation with DSP4: Interactive and Parametric Effects of Clonidine. In: Neurodegenerative Disorders, Palomo, T., R.J. Beninger and T. Archer (Eds.). Sintesis, Madrid, Spain, pp: 181-212.
  122. Archer, T. and A. Fredriksson, 2001. Restoration and Putative Protection in Parkinsonism. In: Neurodegenerative Disorders, Palomo, T., R.J. Beninger and T. Archer (Eds.). Sintesis, Madrid, Spain, pp: 609-665.
  123. Archer, T. and A. Fredriksson, 2000. Restoration and putative protection of MPTP-induced functional deficits. Neurotoxicity Res., 2: 251-292.